Skip to content

A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration

A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration - A study of the effect of the self-care support program created by nurses in order to enhance diet satisfaction for chemotherapy patients with breast cancer who suffer from taste alteration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015477
Enrollment
150
Registered
2014-10-21
Start date
2014-10-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

The support by the nurse using the brochure about the taste alteration Usually support care by the nurse

Sponsors

Hiroshima University Graduate School of Biomedical & Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.The women who were diagnosed as breast cancer newly. 2.20 years of age or over. 3.The patients who receive chemotherapy ( anthracyclines and taxanes)before or after operation. 4.Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. 5.The patients who do not have taste alteration and oral complication or dysphagia. 6.The patients who agree with the study and do not have communication disorder.

Exclusion criteria

Exclusion criteria: 1.The patients stage 4 with advanced breast cancer or the patients recurrent with breast cancer. 2.The patients who received chemotherapy previously because of cancer treatment. 3.The patients who received radiotherapy to oral cavity or salivary gland previously. 4.The patients who had operation to oral cavity previously. 5.The patients who take a medicine which contains zinc currently or previously because of taste alteration. 6.The patients with serious renal disease(more than serum Cr 2.0mg/dL), or receive dialysis. 7.The patients with serious liver disease. 8.The patients with hepatic disorder, mental disorder, an oral cavity malignant tumor and the diabetes. 9.The patients who have already taken a supplement which contains zinc or a medicine which contains zinc. 10.Patients who are excluded by the doctor's judgment.

Design outcomes

Primary

MeasureTime frame
The satisfaction level of the diet by the taste alteration

Countries

Japan

Contacts

Public ContactSanae Asano

Hiroshima University Graduate School of Biomedical & Health Sciences Department of Health Care for Adults

asano-sanae@hiroshima-u.ac.jp082-257-5383

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026